Correlation Between ANI Pharmaceuticals and CALTAGIRONE EDITORE

Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and CALTAGIRONE EDITORE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and CALTAGIRONE EDITORE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ANI Pharmaceuticals and CALTAGIRONE EDITORE, you can compare the effects of market volatilities on ANI Pharmaceuticals and CALTAGIRONE EDITORE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of CALTAGIRONE EDITORE. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and CALTAGIRONE EDITORE.

Diversification Opportunities for ANI Pharmaceuticals and CALTAGIRONE EDITORE

0.23

Correlation Coefficient

ANI Pharmaceuticals  CALTAGIRONE EDITORE

Modest diversification

The 3 months correlation between ANI and CALTAGIRONE is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and CALTAGIRONE EDITORE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CALTAGIRONE EDITORE and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with CALTAGIRONE EDITORE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CALTAGIRONE EDITORE has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and CALTAGIRONE EDITORE go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and CALTAGIRONE EDITORE

Assuming the 90 days trading horizon ANI Pharmaceuticals is expected to generate 4.24 times less return on investment than CALTAGIRONE EDITORE. But when comparing it to its historical volatility, ANI Pharmaceuticals is 1.06 times less risky than CALTAGIRONE EDITORE. It trades about 0.02 of its potential returns per unit of risk. CALTAGIRONE EDITORE is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  91.00  in CALTAGIRONE EDITORE on October 9, 2024 and sell it today you would earn a total of  41.00  from holding CALTAGIRONE EDITORE or generate 45.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ANI Pharmaceuticals  vs.  CALTAGIRONE EDITORE

ANI Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ANI Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, ANI Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

CALTAGIRONE EDITORE

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CALTAGIRONE EDITORE are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CALTAGIRONE EDITORE unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ANI Pharmaceuticals and CALTAGIRONE EDITORE

The main advantage of trading using opposite ANI Pharmaceuticals and CALTAGIRONE EDITORE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, CALTAGIRONE EDITORE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CALTAGIRONE EDITORE will offset losses from the drop in CALTAGIRONE EDITORE's long position.

The idea behind ANI Pharmaceuticals and CALTAGIRONE EDITORE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.